The association of common functional polymorphisms in miR-146a and miR-196a2 and hepatocellular carcinoma risk: Evidence from a meta-analysis

Medicine (United States)

Volumn 93, Issue 29, 2014, Pages e252-

  Peng, Qiliu ^a   Li, Shan ^a   Lao, Xianjun ^a   Chen, Zhiping ^b   Li, Ruolin ^a   Deng, Yan ^a   Qin, Xue ^a  

^a FIRST AFFILIATED HOSPITAL OF GUANGXI MEDICAL UNIVERSITY   (China)

^b GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 146A; MICRORNA 196A2; UNCLASSIFIED DRUG; MIRN146 MICRORNA, HUMAN; MIRN196 MICRORNA, HUMAN;

ASIAN; CANCER RISK; COCHRANE LIBRARY; CONTROLLED STUDY; EMBASE; EVALUATION STUDY; GENETIC ASSOCIATION; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MEDLINE; META ANALYSIS; PRIORITY JOURNAL; REVIEW; SENSITIVITY ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; ASIAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION; GENETICS; LIVER TUMOR;

ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, HEPATOCELLULAR; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LIVER NEOPLASMS; MICRORNAS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84920822682     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000000252     Document Type: Review

References (44)

1. Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin. 2011;61:69-90.
2. Faivre S, Bouattour M, Raymond E. Novel molecular therapies in hepatocellular carcinoma. Liver Int. 2011;31(Suppl 1):151-160.
3. Liu F, Li B, Wei Y, et al. XRCC1 genetic polymorphism Arg399Gln and hepatocellular carcinoma risk: a meta-analysis. Liver Int. 2011;31:802-809.
4. El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology. 2007;132: 2557-2576.
5. Ebert MS, Sharp PA. Roles for microRNAs in conferring robustness to biological processes. Cell. 2012;149:515-524.
6. Fabian MR, Sonenberg N. The mechanics of miRNA-mediated gene silencing: a look under the hood of miRISC. Nat Struct Mol Biol. 2012;19:586-593.
7. Dykxhoorn DM. MicroRNAs and metastasis: little RNAs go a long way. Cancer Res. 2010;70:6401-6406.
8. Kwak PB, Iwasaki S, Tomari Y. The microRNA pathway and cancer. Cancer Sci. 2010;101:2309-2315.
9. Saunders MA, Liang H, Li WH. Human polymorphism at micro-RNAs and microRNA target sites. Proc Natl Acad Sci USA. 2007;104:3300-3305.
10. Chen K, Song F, Calin GA, et al. Polymorphisms in microRNA targets: a gold mine for molecular epidemiology. Carcinogenesis. 2008;29:1306-1311.
11. Akkiz H, Bayram S, Bekar A, et al. No association of premicroRNA-146a rs2910164 polymorphism and risk of hepatocellular carcinoma development in Turkish population: a case-control study. Gene. 2011;486:104-109.
12. Chen C, Zhang Y, Zhang L, et al. MicroRNA-196: critical roles and clinical applications in development and cancer. J Cell Mol Med. 2011;15:14-23.
13. Wang J, Wang Q, Liu H, et al. The association of miR-146a rs2910164 and miR-196a2 rs11614913 polymorphisms with cancer risk: a meta-analysis of 32 studies. Mutagenesis. 2012;27:779-788.
14. Hoffman AE, Zheng T, Yi C, et al. microRNA miR-196a-2 and breast cancer: a genetic and epigenetic association study and functional analysis. Cancer Res. 2009;69:5970-5977.
15. Xu T, Zhu Y, Wei QK, et al. A functional polymorphism in the miR-146a gene is associated with the risk for hepatocellular carcinoma. Carcinogenesis. 2008;29:2126-2131.
16. Li XD, Li ZG, Song XX, et al. A variant in microRNA-196a2 is associated with susceptibility to hepatocellular carcinoma in Chinese patients with cirrhosis. Pathology. 2010;42:669-673.
17. Qi P, Dou TH, Geng L, et al. Association of a variant in MIR 196A2 with susceptibility to hepatocellular carcinoma in male Chinese patients with chronic hepatitis B virus infection. Hum Immunol. 2010;71:621-626.
18. Zhang XW, Pan SD, Feng YL, et al. [Relationship between genetic polymorphism in microRNAs precursor and genetic predisposition of hepatocellular carcinoma]. Zhonghua Yu Fang Yi Xue Za Zhi. 2011;45:239-243.
19. Zhou J, Lv R, Song X, et al. Association between two genetic variants in miRNA and primary liver cancer risk in the Chinese population. DNA Cell Biol. 2012;31:524-530.
20. Han Y, Pu R, Han X, et al. Associations of pri-miR-34b/c and premiR-196a2 polymorphisms and their multiplicative interactions with hepatitis B virus mutations with hepatocellular carcinoma risk. PLoS ONE. 2013;8:e58564.
21. Xu Y, Li L, Xiang X, et al. Three common functional polymorphisms in microRNA encoding genes in the susceptibility to hepatocellular carcinoma: a systematic review and meta-analysis. Gene. 2013;527:584-593.
22. Zhang J, Wang R, Ma YY, et al. Association between single nucleotide polymorphisms in miRNA196a-2 and miRNA146a and susceptibility to hepatocellular carcinoma in a Chinese population. Asian Pac J Cancer Prev. 2013;14:6427-6431.
23. Shan YF, Huang YH, Chen ZK, et al. miR-499A>G rs3746444 and miR-146aG>C expression and hepatocellular carcinoma risk in the Chinese population. Genet Mol Res. 2013;12:5365-5371.
24. Kou JT, Fan H, Han D, et al. Association between four common microRNA polymorphisms and the risk of hepatocellular carcinoma and HBV infection. Oncol Lett. 2014;8:1255-1260.
25. Chu YH, Hsieh MJ, Chiou HL, et al. MicroRNA gene polymorphisms and environmental factors increase patient susceptibility to hepatocellular carcinoma. PLoS ONE. 2014;9:e89930.
26. Cong N, Chen H, Bu WZ, et al. miR-146a G>C polymorphisms and risk of hepatocellular carcinoma in a Chinese population. Tumour Biol. 2014;35:5669-5673.
27. Zhou B, Dong LP, Jing XY, et al. Association between miR-146aG>C and miR-196a2C>T polymorphisms and the risk of hepatocellular carcinoma in a Chinese population. Tumour Biol. 2014;35:7775-7780.
28. Wang XH, Wang FR, Tang YF, et al. Association of miR-149C>T and miR-499A>G polymorphisms with the risk of hepatocellular carcinoma in the Chinese population. Genet Mol Res. 2014;13: 5048-5054.
29. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-Analysis of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283:2008-2012.
30. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177-188.
31. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719-748.
32. Duval S, Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000;56:455-463.
33. Kim HY, Yoon JH, Lee HS, et al. MicroRNA-196A-2 polymorphisms and hepatocellular carcinoma in patients with chronic hepatitis B. J Med Virol. 2014;86:446-453.
34. Akkiz H, Bayram S, Bekar A, et al. A functional polymorphism in pre-microRNA-196a-2 contributes to the susceptibility of hepatocellular carcinoma in a Turkish population: a case-control study. J Viral Hepat. 2011;18:e399-e407.
35. Xiang Y, Fan S, Cao J, et al. Association of the microRNA-499 variants with susceptibility to hepatocellular carcinoma in a Chinese population. Mol Biol Rep. 2012;39:7019-7023.
36. Kim WH, Min KT, Jeon YJ, et al. Association study of microRNA polymorphisms with hepatocellular carcinoma in Korean population. Gene. 2012;504:92-97.
37. Chen T, Li Z, Yan J, et al. MicroRNA expression profiles distinguish the carcinogenic effects of riddelliine in rat liver. Mutagenesis. 2012;27:59-66.
38. He L, Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet. 2004;5:522-531.
39. Ryan BM, Robles AI, Harris CC. Genetic variation in microRNA networks: the implications for cancer research. Nat Rev Cancer. 2010;10:389-402.
40. Jazdzewski K, Liyanarachchi S, Swierniak M, et al. Polymorphic mature microRNAs from passenger strand of pre-miR-146a contribute to thyroid cancer. Proc Natl Acad Sci USA. 2009;106: 1502-1505.
41. Jazdzewski K, Murray EL, Franssila K, et al. Common SNP in premiR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma. Proc Natl Acad Sci USA. 2008;105:7269-7274.
42. Zhang Z, Wang M, Wu D, et al. P53 codon 72 polymorphism contributes to breast cancer risk: a meta-analysis based on 39 case-control studies. Breast Cancer Res Treat. 2010;120:509-517.
43. Mitchell AA, Cutler DJ, Chakravarti A. Undetected genotyping errors cause apparent overtransmission of common alleles in the transmission/disequilibrium test. Am J Hum Genet. 2003;72: 598-610.
44. Ioannidis JP, Patsopoulos NA, Evangelou E. Uncertainty in heterogeneity estimates in meta-analyses. BMJ. 2007;335:914-916.